BACKGROUND: Remnant @entity165 (RC) is receiving increasing attention regarding its relation to cardiovascular risk. Whether RC is associated with periprocedural @entity296 (PMI) following percutaneous coronary intervention (PCI) in @entity2175 ( @entity2175 ) is currently unknown. METHODS: We prospectively enrolled 1182 consecutive @entity2175 @entity1 who were scheduled for PCI but with baseline normal preprocedural @entity6949 ( @entity6949 ). @entity1 were divided according to their glycemic control status: group A [glycated hemoglobin (HbA1c)<7%, n=563] and group B (HbA1c>= 7%, n=619). PMI was evaluated by @entity6949 analysis within 24h. The associations of preprocedural RC and the RC to high-density lipoprotein @entity165 ratio (RC/HDL-C) with PMI were investigated. RESULTS: The associations of RC and RC/HDL-C with PMI were observed in group B (both p<0.05) but not in group A (both p>0.05). @entity1 in group B, a 1-SD increase of RC produced 30% and 32% increased risk for postprocedural @entity6949 >3* upper limit of normal (ULN) and >5*ULN, respectively. The odds ratios for RC/HDL-C were the highest compared with any @entity165 fractions including total @entity165 (TC)/HDL-C, low density lipoprotein @entity165 (LDL-C)/HDL-C, nonHDL-C/HDL-C, and @entity412 /HDL-C with 1.43 [95% confidence interval (CI): 1.10-1.88] for >3* ULN and 1.49 (95% CI: 1.13-1.97) for >5* ULN. However, no such associations were found in group A. Furthermore, @entity1 with RC >27.46mg/dL (third tertile) [RC<= 14.15mg/dL (first tertile) as reference] were associated with a 1.57-fold and 2-fold increased risk for >3* ULN and >5* ULN in group B, respectively. CONCLUSIONS: RC and RC/HDL-C might be valuable, independent predictors for PMI in poorly-controlled @entity6 @entity1 undergoing PCI.

Remnant XXXX predicts periprocedural @entity296 following percutaneous coronary intervention in poorly-controlled @entity2175 .

@entity2175 :: ('MESH:D003924', 'Disease') :: ['type 2 diabetes', 'T2D'] @entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity296 :: ('MESH:D009202', 'Disease') :: ['myocardial injury'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetic'] @entity6949 :: ('7137', 'Gene') :: ['cTnI', 'cardiac troponin I'] @entity412 :: ('CHEBI:17855', 'Chemical') :: ['triglyceride'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol']
@entity165 :: (MESH:D002784,Chemical) :: ['cholesterol']
